Observational studyBMC women's health2025
Comparison of quality of life in patients with endometriosis undergoing treatment with progestins, oral contraceptives pills (OCP), and GnRH agonists.
Observational study in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Clinical and endocrine effects of pharmacological therapy in endometriosis: a systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
- GnRH Analogues for the Treatment of Endometriosis-Related Pain: A Narrative Review.Journal of clinical medicine · 2026Review
- Endometriosis-Associated Infertility: A Review of Pathophysiological Mechanisms and Current Treatment Strategies.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe objective of this study was to compare the quality of life in patients with endometriosis undergoing treatment with progestins, OCPs, and GnRH agonists.
methodsThis prospective, observational, and comparative study was conducted on patients with endometriosis at Amir al-Momenin Hospital (Zabol, Iran) from 2022 to 2024. The Endometriosis Health Profile (EHP-30) questionnaire was used to utilized patients' quality of life.
resultsThe study included three groups of women using OCPs, progestins, and GnRH agonists, consisting of 39, 74, and 22 participants, respectively. No significant differences were observed among the three groups with regard to occupation, education, marital status, physical activity, coffee consumption, or tobacco and alcohol use. However, a number of significant differences were identified in nutritional status, dyschezia, and psychological disorders. No statistically significant differences were observed in quality-of-life scores among the three groups (P = 0.197).
conclusionThe three treatment approaches demonstrated comparable outcomes in terms of the quality of life of patients diagnosed with endometriosis. However, the observed differences in certain demographic and psychological health variables underscore the necessity to consider factors beyond pharmacological treatment to enhance the quality of life in these patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.